BRAF V600E mutant papillary craniopharyngiomas: a single-institutional case series.
Emanuele La CorteIyan YounusFrancesca PivariAdelina SelimiMalte OttenhausenJonathan A ForbesDavid J PisapiaGeorgiana A DobriVijay K AnandTheodore H SchwartzPublished in: Pituitary (2018)
BRAF V600E mutant papillary tumors represent a clearly distinct clinical-pathological entity of craniopharyngiomas. These are generally non-calcified suprasellar tumors that occur in adults. These distinct characteristics may someday lead to upfront chemotherapy. When surgery is necessary, EEA may be preferred over TCA.